MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: iHealthcareAnalyst, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Acute Myeloid Leukemia Treatment Market to Reach US$ 1.17 Billion by 2021 According to iHealthcareAnalyst, Inc. - The global acute myeloid leukemia treatment market expected to reach US$ 1.17 billion by 2021, growing at CAGR 15% over the forecast period 2017-2021, owing to introduction of high-priced products and strong pipeline of upcoming drugs
Global Acute Myeloid Leukemia Treatment Market to Reach US$ 1.17 Billion by 2021 According to iHealthcareAnalyst, Inc.

 

NewswireToday - /newswire/ - Maryland Heights, MO, United States, 2017/09/28 - The global acute myeloid leukemia treatment market expected to reach US$ 1.17 billion by 2021, growing at CAGR 15% over the forecast period 2017-2021, owing to introduction of high-priced products and strong pipeline of upcoming drugs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Acute Myeloid Leukemia Treatment Market by Drug Type - Hypomethylating Agents - Vidaza (Azacitidine), Dacogen (Decitabine), Cytarabine-based Chemotherapy Drugs, Others; by Pipeline Analysis (Phase III Drugs) - Chemotherapy Drugs, Vyxeos (Fixed-combination Drugs: Daunorubicin and Cytarabine); Kinase Inhibitors (Midostaurin, Quizartinib) and Forecast 2017-2021

The global acute myeloid leukemia treatment market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global acute myeloid leukemia treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global acute myeloid leukemia treatment market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.

The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments. Major players operating in the global acute myeloid leukemia treatment market and profiled in this report include Astellas Pharma, Astex Pharmaceuticals, Bayer, Boehringer Ingelheim, Celgene (Agios Celgene), Cyclacel Pharmaceuticals, Daiichi Sankyo, Jazz Pharmaceuticals, Novartis, Onyx Pharma, Otsuka Pharmaceuticals, Pfizer, Roche, Seattle Genetics, Sunesis Pharmaceuticals, and Synta Pharmaceuticals.

1. Drug Type
1.1. Hypomethylating Agents
1.1.1. Vidaza (Azacitidine)
1.1.2. Dacogen (Decitabine)
1.2. Cytarabine-based Chemotherapy Drugs
1.3. Others

2. Pipeline Analysis (Phase III Drugs)
2.1. Chemotherapy Drugs
2.2. Vyxeos (Fixed-combination Drugs: Daunorubicin and Cytarabine)
2.3. Kinase Inhibitors
2.3.1. Midostaurin
2.3.2. Quizartinib

3. Geography
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC
3.5. Rest of the World

4. Company Profiles
4.1. Astellas Pharma
4.2. Astex Pharmaceuticals
4.3. Bayer
4.4. Boehringer Ingelheim
4.5. Celgene (Agios Celgene)
4.6. Cyclacel Pharmaceuticals
4.7. Daiichi Sankyo
4.8. Jazz Pharmaceuticals
4.9. Novartis
4.10. Onyx Pharma
4.11. Otsuka Pharmaceuticals
4.12. Pfizer
4.13. Roche
4.14. Seattle Genetics
4.15. Sunesis Pharmaceuticals
4.16. Synta Pharmaceuticals

To request Table of Contents and Sample Pages of this report visit our website.

About iHealthcareAnalyst, Inc.

iHealthcareAnalyst, Inc. (ihealthcareanalyst.com) is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: iHealthcareAnalyst, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Global Acute Myeloid Leukemia Treatment Market to Reach US$ 1.17 Billion by 2021 According to iHealthcareAnalyst, Inc.

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Ana Aitawa - iHealthcareAnalyst.com 
314-500-7508 sales[.]ihealthcareanalyst.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any iHealthcareAnalyst, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From iHealthcareAnalyst, Inc. / Company Profile


Read Health / Surgery Most Recent Related Newswires:

The American Psychiatric Association Selects Wiley to Publish its Open Access Journal Psychiatric Research and Clinical Practice
South Carolina Launches Emergency Supply Portal to Connect Providers with Organizations in Need
EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability Finds Frost & Sullivan
South Carolina’s Humimic Medical Arming Healthcare Workers for the COVID-19 War
SCBIO Executive Erin Ford Appointed to South Carolina District Export Council for 2020-2021
University of the Ryukyus and NEC Discover a Novel Diagnostic Biomarker for Acute Adult T-cell Leukemia/lymphoma
Change Healthcare Recognized by Frost & Sullivan for Accelerating Claims Processing with its Intelligent Healthcare Network™ Blockchain Technology
SCBIO CEO Sam Konduros Named to South Carolina Chamber Executive Committee
Frost & Sullivan Defines Top Femtech Global Opportunities by 2024
Frost & Sullivan Highlights on Impact of the Coronavirus on Business
Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan
Inkwood Research Publishes Global Genetic Testing Market Forecast 2019-2027
NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Digital45 | Studio45 IT Services (P) Ltd

Visit  JobsWare.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)